Robert Ford, Chairman and CEO, reported organic sales growth of 7.5% excluding COVID test sales, highlighting double-digit growth in Medical Devices and high single-digit growth in Established ...
Boudreau guided for Q3 adjusted EPS of $1.28 to $1.32. Management reaffirmed full-year expectations of high single-digit growth and double-digit EPS growth, despite headwinds from diagnostics and ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results